Comparison of Cranioplasty With PEEK and Titanium
Launched by RENJI HOSPITAL · Jan 12, 2021
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
Decompressive craniectomy (DC) is suggested as an effective surgical intervention for patients with high intracranial pressure. For the skull defect after DC, cranioplasty could pro-vide protection, aesthetic and even functional improvements. The autologous bone flap (ABF) was once thought to be an optimal autograft for repairing \[8\]. While accumulated studies reported ABF related disadvantages. Recently, various customized artificial materials are increasingly employed, e.g., titanium and polyetheretherketone (PEEK).
Titanium is a widely applied metal material for cranioplasty, attribut...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients underwent cranioplasty with PEEK or Titanium.
- • Patients underwent cranioplasty and had complete data and 6-month follow-up records.
- Exclusion Criteria:
- • Patients underwent cranioplasty with other material or ABF.
- • Patients had incomplete data or follow-up records.
About Renji Hospital
Renji Hospital, a prestigious medical institution affiliated with Shanghai Jiao Tong University School of Medicine, is dedicated to advancing healthcare through innovative clinical research. With a strong emphasis on patient-centered care, Renji Hospital conducts a wide range of clinical trials across various therapeutic areas, harnessing cutting-edge technology and evidence-based practices. The hospital's multidisciplinary team of experienced researchers and medical professionals collaborates closely to ensure rigorous study design and execution, aiming to contribute significantly to medical knowledge and improve treatment outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials